Equity Analysis /
United States of America

US : Aerie Pharmaceuticals, Inc. - AERI | Weekly Rx Metrics

    Lucas Lee
    Lucas Lee

    Sr. Res. Assoc.

    Follow
    CGS-CIMB
    25 January 2021
    Published byCGS-CIMB

    Updated product metrics based on weekly prescription trends for key Aerie Pharmaceuticals products are herein. With the latest weekly Rxs, we estimate Aerie’s combined glaucoma franchise is annualizing at $81M in sales.RhopressaRhopressa is in its 32nd month of full-scale launch, and the latest wee